Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 Michel_2017
%A Michel, Christiane
%A Scosyrev, Emil
%A Petrin, Michael
%A Schmouder, Robert
%D 2017
%I Springer Science and Business Media LLC
%J Clinical Drug Investigation
%K ADR SpontaneousReporting disproportionality pharmacovigilance
%N 5
%P 415--422
%R 10.1007/s40261-017-0503-6
%T Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
%U https://doi.org/10.1007%2Fs40261-017-0503-6
%V 37
@article{Michel_2017,
added-at = {2023-02-24T13:41:09.000+0100},
author = {Michel, Christiane and Scosyrev, Emil and Petrin, Michael and Schmouder, Robert},
biburl = {https://www.bibsonomy.org/bibtex/2bbc96610dd21a7aa797541fd48a9589b/jepcastel},
doi = {10.1007/s40261-017-0503-6},
interhash = {c27ef1c420128422b708c7e66f263273},
intrahash = {bbc96610dd21a7aa797541fd48a9589b},
journal = {Clinical Drug Investigation},
keywords = {ADR SpontaneousReporting disproportionality pharmacovigilance},
month = feb,
number = 5,
pages = {415--422},
publisher = {Springer Science and Business Media {LLC}},
timestamp = {2023-05-03T10:14:14.000+0200},
title = {Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?},
url = {https://doi.org/10.1007%2Fs40261-017-0503-6},
volume = 37,
year = 2017
}